JP Morgan Call 60 ZM 17.05.2024/ DE000JB4CVV7 /
13/05/2024 09:52:36 | Var.+0.040 | Denaro21:55:01 | Lettera21:55:01 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.210EUR | +23.53% | 0.300 Quantità in denaro: 3,000 |
0.340 Quantità in lettera: 3,000 |
Zoom Video Communica... | 60.00 USD | 17/05/2024 | Call |
GlobeNewswire
22:10
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of ...
GlobeNewswire
22:05
Infinera Corporation Fourth Quarter and Fiscal 2023 Summary of Key Financial Results
GlobeNewswire
22:05
NEXGEL Reports First Quarter 2024 Revenue of $1.27 Million, an Increase of 104% Year-Over-Year
GlobeNewswire
22:05
Kandi Technologies to Report First Quarter 2024 Financial Results and Hold a Conference Call on May ...
GlobeNewswire
22:05
CompoSecure Chief Product & Innovation Officer to Speak at Seamless Middle East 2024
GlobeNewswire
22:05
Capricor Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
22:05
scPharmaceuticals to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
GlobeNewswire
22:05
Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results
GlobeNewswire
22:05
Banzai Continues Strong Organic Growth with the Addition of Over 230 Customers in April
GlobeNewswire
22:05
180 Degree Capital Corp. Reports Net Asset Value per Share (“NAV”) of $5.16 as of March 31, 2024